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Equine influenza (EI) virus is one of the most economically important pathogens of respiratory diseases of 
horses worldwide. Despite availability of vaccines for control of EI, the highly contagious nature and variability 
properties of the virus mean global outbreaks occur. Thus, continuous surveillance programs, including 
seroprevalence studies of disease in different countries, may contribute to better control of the disease. In this 
study, the seroprevalence of equine influenza in 850 horses from Brazil was investigated. The serodiagnosis was 
based on the single radial hemolysis (SRH) assay using influenza A/equine/Richmond/1/2007 (H3N8) antigen. 
Antibodies against A/equine/Richmond/1/07 (H3N8) were detected in 44.7% (380/850, 95% CI: 41.4–48.1%) 
of horses. Seroprevalence was significantly lower (p=0.001) in younger animals (< 5 years, 38.6%) than in 
‘adult’ animals (5–14 years, 52.1%). There was also a significant relationship between the year of sampling and 
seroprevalence (p<0.0005). The mean SRH antibody value was 42.0 mm2 (range 4–238.9 mm2), with the 
majority of horses (95.3%) having an SRH value 150 mm2, which is considered an insufficient level for 
protection of equine hosts against influenza infections and potential virus shedding. These findings indicate the 
need to reinforce preventive/control measures against equine influenza in Brazil. 
 
Introduction 
Alphainfluenzavirus, a renamed genus in the Orthomyxoviridae family [1], is comprised of emerging and re-
emerging animal and human diseases associated with severe respiratory infections worldwide. Particularly, the 
equine influenza virus (EIV) is the causative agent of equine influenza (EI). It is one of the most economically 
important pathogens causing respiratory disorders of horses worldwide because of its rapid spread and highly 
contagious nature among susceptible hosts. Influenza A viruses of the H3N8 subtype were first isolated from 
horses in 1963. The equine H3N8 virus is thought to have emerged in South America; phylogenetic analysis 
demonstrated that genes of the virus isolated from horses shared a most recent common ancestor with avian 
strains circulating in Argentina, Bolivia, Brazil and Chile a few years before it was first isolated [2]. The equine 
H3N8 virus was imported to the USA in 1963 when Thoroughbred horses were transported by air from 
Argentina [3] and further spread to Europe causing an epidemic in 1965. Further major epidemics of equine 
H3N8 influenza occurred in 1979–1981, 1989 and 2003. The first Brazilian outbreak caused by the H3N8 
subtype occurred in 1963 and, subsequently, outbreaks have been reported regularly [4,5].  
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Initially, the equine H3N8 viruses evolved in a single genetic lineage, but in 1989, divergent evolution led to 
distinct lineages of viruses circulating in the Americas on the one hand and Europe and Asia on the other [6]. 
The ‘American’ lineage further diverged into the ‘Florida’ and ‘Kentucky’ sub-lineages [7] and finally, the 
‘Florida’ sub-lineage has been further classified as clade 1 or clade 2, with clade 1 viruses initially predominant 
in the Americas and clade 2 in Europe [8].  
Equine influenza vaccines were introduced shortly after the emergence of the H3N8 virus. The World 
Organisation for Animal Health (OIE) has overseen a vaccine strain review program for equine influenza since 
the 1990s; the latest recommendation from the expert surveillance panel (April 2019) is that vaccines should 
contain both clade 1 and clade 2 viruses of the Florida sub-lineage [9].  
In 2018/2019, widespread outbreaks of EI caused by Florida clade 1 viruses have been reported. These were 
initially identified in South America [10] and subsequently spread to European countries [11]. This recurrent 
emergence of epidemics of equine influenza from South America emphasizes the need for monitoring the status 
of equine influenza in South American countries, including Brazil. 
In previous serological surveys of equine influenza in Brazil, the hemagglutination inhibition (HI) test has been 
used to determine seropositivity [12]. However, the HI test is not readily standardized. In experimental 
infections of ponies, only animals with antibody levels greater than 154 mm2 measured by single radial 
hemolysis (SRH) assay were protected against infection with an antigenically-related equine influenza strain, 
although animals with SRH levels above 85 mm2 did not show clinical signs of disease and therefore could 
‘silently’ shed virus [13]. Further analysis of data from vaccination and challenge studies and natural outbreaks 
of EI among vaccinated horses allowed a threshold of 150 mm2 to be defined above which horses were 
protected against infection with virus related to strains included in vaccines [14]. Thus, serological surveillance 
using the SRH assay can give a more precise evaluation of the numbers of animals likely to have protective 
immunity. 
In this study, the seroprevalence of equine influenza in 850 horses in Brazil based on single radial hemolysis 
(SRH) was investigated.   
Materials and Methods 
This study was approved by the Ethics Committee on Animal Use (CEUA) guidelines of the School of 
Veterinary Medicine and Animal Sciences, São Paulo State University, UNESP, Botucatu, SP, Brazil (protocol 
number 155/2018). 
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Sample collection and serological analyses 
A convenience serum sample was collected once from 850 horses for equine infectious anemia testing, which is 
mandatory in Brazil for movement of equids, between 2005 and 2017. Blood (10 mL) was aseptically collected 
from the jugular by venipuncture. The horses belonged to farms from the southwest region of Brazil, where 
equine rearing is common. The horses were used for farm work, sport, and/or leisure activities and, at sample 
collection, none presented with pulmonary signs compatible with EI. 
Data including age, sex (male/female) and breed, and location (state) and year of sampling were collected. 
There was no consistent data regarding the status of influenza vaccination among horses sampled, and this 
information was not used to further analysis. 
Antibody levels against influenza A/equine/Richmond/1/2007 (H3N8), a representative of Florida clade 1, were 
measured using the single radial hemolysis (SRH) assay performed as described in the OIE Manual of 
Diagnostic Tests and Vaccines for Terrestrial Animals [9]. The area of zones of hemolysis (mm2) were 
calculated from the diameter measured using digital calipers. All SRH areas below the lower limit of detection 
(4 mm2; [15]) were set to 4 for analysis.  
Statistical analysis 
Overall seroprevalence was estimated using the Wilson method to determine confidence limits [16]. Pearson’s 
chi-square test was used to find associations between serological results and explanatory variables in SPSS 25.0 
(Statistical Package for Social Sciences, Inc., Chicago, IL, USA). For statistical analysis, animals were divided 
into three age categories (<5 years = ‘young’, 5–14  years = ‘adult’, and 15 years = ‘old’). Due to the 
occasional use of the same horse in two activities, this parameter was not considered in further statistical 
analysis. 
Results 
Antibodies against influenza A/equine/Richmond/1/2007 (H3N8) were detected in 380 of the 850 horses tested 
giving an overall seroprevalence of 44.7% (95% CI: 41.4–48.1%).  
There was no significant difference in seroprevalence between male and female or mixed and pure-breed horses 
or location of sampling, however the majority of samples (82%) were obtained from São Paulo state (Table 1). 
There was a significant difference in seroprevalence according to age (𝜒2 =3.30, p=0.001), with 52.1% of ‘adult’ 
and 50.7% of ‘old’ horses versus 38.6% of ‘young’ horses seropositive. The age range of animals sampled was 
from 4 days to 33 years. There was also a significant relationship between year of sampling and seroprevalence, 
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𝜒2 =41.11, p<0.0005 with the highest seroprevalence in 2005 (64.3%) and lowest seroprevalence (around 31%) 
in 2009–2011. 
The mean SRH antibody value was 52.7 mm2 (range 4–238.9 mm2), a low antibody level likely to be 
insufficient clinical protection as it is below the threshold of 85 mm2. Furthermore, only 4.7% of horses had 
SRH antibody levels above 150 mm2, associated with protection against infection, and only 19.8% had levels 
between 85 and 150 mm2. When individual SRH antibody values were plotted for different age groups (Figure 
1), it was apparent that the highest mean SRH values were seen in horses aged 1 month or less (75.63 mm2) but 
with a clear division with half of the foals having SRH values 109.8–193.9 mm2 and half (6/12) having values 
of 4–34.8 mm2. Mean SRH values were similar in all other age groups (35.9–58.3 mm2). The highest median 
SRH values were also seen in horses 1-month-old or less (72.3 mm2). However, the median SRH value was 
lower in 29 horses classified as 6 months old (33.6%) and the median value in horses aged 1–4 years was below 
the lower limit of detection (4 mm2). In 5–9-year-old horses, the median SRH value was 51.0 mm2, but was 
again 4 mm2 in horses aged 10 years or older. 
Discussion 
The seroprevalence of equine H3N8 influenza estimated using SRH in this study was 44.7% (95% CI: 41.4–
48.1%). This value is in good agreement with the mean (52%) and mode (42%) seroprevalence estimated from 
HI data in 14 studies in different states and regions from Brazil published between 1985 and 2014 [12]. 
Prevention and control of EI is based mainly on biosecurity procedures and vaccination. Mathematical 
modelling has been used to demonstrate that vaccination of around 40% of an equine population with an 
effective EI vaccine will reduce virus transmission sufficiently to provide herd immunity [17]. However, 
modelling also demonstrated that where there is an antigenic mismatch between a vaccine strain and challenge 
strain, even very high levels of SRH antibody may not afford protection and more animals must be vaccinated to 
achieve herd immunity.  
In the current study, seroprevalence differed significantly between different age groups of horses, with the 
highest seropositivity (52.1%) in adult horses (aged 5–14 years) when compared with horses under 5 years of 
age (38.6%). Similarly, Jurado-Tarifa et al. [18] found the main risk factor associated with equine H3N8 
influenza seroprevalence in Spain was age; significantly higher seropositivity was observed in old or geriatric 
(odds ratio, OR = 6.1, P = 0.008, 95% CI = 1.6–23.1) and adult (OR = 4.8, P < 0.001, 95% CI = 2.5–9.0) horses 
compared to young animals. The higher seroprevalence of adult horses could be attributed to repeated exposure 
of these animals to equine influenza virus or vaccination. In Brazil, movement of horses between states or entry 
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to equestrian events requires a certificate confirming that the horse has been vaccinated against EI (maximum 
360 days prior to transit) or a certificate confirming that no clinical cases or outbreaks of infectious diseases 
(including equine influenza) occurred at the farm of origin 30 days before issuing an animal movement permit 
[19]. Nevertheless, no consistent data are available regarding vaccination/revaccination status of the horses 
sampled, which may be considered a limitation of the current study.  
In addition to horse age, the year of sampling was identified as a risk factor for seropositivity in this study with 
the highest seroprevalence value in 2005. In the period 2005–2017, the most outbreaks of EI reported to the OIE 
in any one year was 144 outbreaks in 2006 (https://www.oie.int/wahis_2/public/wahid.php/Wahidhome/Home). 
During 2009–2011, when seroprevalence values were lowest in this study, a total of 86 outbreaks were reported 
over the 3 years. In 2012, there was an extensive outbreak of EI in South America that was first reported in 
Chile then spread to Brazil (129 outbreaks were notified to the OIE), Uruguay and Argentina, where both 
vaccinated and unvaccinated animals were affected by a Florida clade 1 strain [20]. Although no outbreaks were 
reported to the OIE in 2015–2017, an outbreak was identified in vaccinated and unvaccinated horses in a 
veterinary school hospital in São Paulo in 2015, again caused by a Florida Clade 1 strain [4].  
SRH is a reliable in vitro assay that is more reproducible than hemagglutination (HI) for measuring antibodies 
against equine influenza [21]. Evidence supports that levels above 150 mm2 of antibodies measured by SRH are 
required for protection of the host against challenge with a similar influenza virus strain [14]. Recently, a large-
scale serological study with 2,645 analyzed serum samples of horses in France found that 12.4% (n=328) had 
antibody levels below 85 mm2 (risk of infection), 27.3% between ≥85 mm2 and <154 mm2 (horses clinically 
protected), and 60.3% ≥154 mm2 [22]. In contrast, in the present study, the mean SRH antibody level was 42.0 
mm2 (range 4–238.9 mm2), with the majority of horses (95.3%) having an antibody values below the protective 
level of 150 mm2 [14]. This finding indicates the need to emphasize prevention and control measures targeting 
EI in Brazil, mainly biosecurity and vaccination procedures, as this country possesses one of the largest 
population of horses globally, estimated 6 million horses [23] and, with the addition of mules and donkeys, 
close to 10 million equids.      
Understanding the age-related SRH antibody profile may help inform targeted vaccination strategies. The two 
distinct clusters of higher or lower SRH antibody levels in foals aged 1 month or less in this study suggests that 
the dams of at least half were vaccinated during pregnancy to confer maternally-derived antibodies (MDA). The 
median level of MDA in foals classified as 6-months old was around half of that in foals 1 month or less and the 
median level had declined to below the limit of detection of the SRH assay in young horses between 1 and 4 
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years of age. The median SRH value of 51.0 mm2 in horses aged 5–9 years most likely reflects greater 
likelihood of exposure to virus through mixing with other horses and / or vaccination. However, further studies 
are needed to better understand vaccine uptake in this equine population.     
Overall, this study revealed influenza seroprevalence of 44.7% in horses in Brazil. However, the generally low 
SRH antibody levels revealed in sampled horses reinforces the need for control measures against the disease, 
particularly adequate vaccination approaches. 
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Table 1 Univariate analysis of risk factors associated with equine influenza virus seropositivity determined by 
single radial hemolysis (SRH) assay among 850 Brazilian horses  
Factor Level SRH P value 
Positive Total % prevalence (95% CI) 
Sex Male 180  417 43.17 (38.50–47.96) 
0.653 
 Female 190 425 44.71 (40.05–49.46) 
Age Young (<5 years) 182 471 38.64 (34.35–43.11) 
0.001  Adult (5–14 years) 134 257 52.14 (46.05–58.17) 
 Old (15 years) 36 71 50.70 (39.34–61.99) 
Breed Mixed 100 255 39.22 (33.43–45.33) 
0.065 
 ‘Pure’1 271 388 46.09 (42.10–50.13) 
State2 São Paulo 311 697 44.62 (40.97–48.33) 
0.389 
 Paraná 15 34 44.12 (28.88–60.55) 
 Santa Catarina 10 25 40.00 (23.40–59.26) 
 Mato Grosso 11 21 52.38 (32.37–71.66) 
 Espírito Santo 10 20 50.00 (29.93–70.07) 
 Rio Grande do Sul 5 15 33.33 (15.18–58.29) 
 Goiás 6 15 40.00 (19.82–64.25) 
 Mato Grosso do Sul 1 11 9.09 (1.62–37.74) 
Year 2005 54 84 64.29 (53.62–73.70) 
0.0005 
 2006 72 130 55.38 (46.81–63.65) 
 2007 87 182 47.80 (40.67–55.03) 
 2008 40 119 33.61 (25.76–42.50) 
 2009 30 96 31.25 (22.85–41.09) 
 2010 20 65 30.77 (20.89–42.80) 
 2011 6 19 31.58 (15.36–53.99) 
 2012 19 50 38.00 (25.86–51.85) 
 2013 16 31 51.61 (34.84–68.03) 
 2014 15 33 45.45 (29.84–62.01) 
 2015 & 20163 7 14 50.00 (26.80–73.20) 
 2017 10 27 37.04 (21.53–55.77) 
 
1Pure-breed horses included: Appaloosa (n=44), Arabian (n=55), Brazilian pony (n=31), Campolina (n=59), 
Mangalarga (n=138), Paint horse (n=41), Quarter horse (n=145), Thoroughbred (n=43), Other (n=32, Crioulo, 
Andaluz, Brazilian sport horse, Breton, Lusitana, American trotter, Minihorse, Friesian, Westfalen, Haflinger). 
2As the numbers sampled in Minas Gerais (N=10) and Rondônia (N=2) were too low to meet the assumption 
that no cells have an expected count of <5 in the Pearson’s chi-squared test, they were not included in analysis. 
3In order to meet the assumption that no cells have an expected count of <5, samples obtained in 2015 and 2016 




Fig. 1 Single radial hemolysis (SRH) values of equine influenza. Dotted lines represent the thresholds for 
clinical and virologic protection at 150 mm2 and clinical protection only at 85 mm2. 
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